What is TG Therapeutics's change in other liabilities?

TG Therapeutics (TGTX) reported change in other liabilities of -$1.62M in Q1 2026.

How has TG Therapeutics's change in other liabilities changed year-over-year?

TG Therapeutics's change in other liabilities increased by 12.8% year-over-year, from -$1.86M to -$1.62M.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

TG Therapeutics TGTX Change in Other Liabilities

Change in Other Liabilities at other companies

BiogenBIIB

-$62M-38.8%

BridgeBio PharmaBBIO

$4.62M+56.8%

Krystal Biotech, Inc.KRYS

$1.44M+169%

LQD

Liquidia CorporationLQDA

$873K—

Roivant SciencesROIV

-$252K-230%

Johnson & JohnsonJNJ

-$629M+90.3%

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Gross profit$171.4M+62.8%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Reported directly by TG Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherCurrentLiabilities.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's change in other liabilities?: TG Therapeutics (TGTX) reported change in other liabilities of -$1.62M in Q1 2026.
How has TG Therapeutics's change in other liabilities changed year-over-year?: TG Therapeutics's change in other liabilities increased by 12.8% year-over-year, from -$1.86M to -$1.62M.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.